Long-Term Effects of Extended-Release Mixed Amphetamine Salts Treatment of Attention- Deficit/Hyperactivity Disorder on Growth

2005 ◽  
Vol 15 (2) ◽  
pp. 191-202 ◽  
Author(s):  
Stephen V. Faraone ◽  
Joseph Biederman ◽  
Michael Monuteaux ◽  
Thomas Spencer
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Extended Release ◽  
Long Term Effects ◽  
Hyperactivity Disorder

scholarly journals Long-term Effects of Multimodal Treatment on Adult Attention-Deficit/Hyperactivity Disorder Symptoms

2019 ◽  
Vol 2 (5) ◽  
pp. e194980 ◽  
Author(s):  
Alexandra P. Lam ◽  
Swantje Matthies ◽  
Erika Graf ◽  
Michael Colla ◽  
Christian Jacob ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Multimodal Treatment ◽  
Long Term Effects ◽  
Hyperactivity Disorder

Methylphenidate and substance abuse: A review of pharmacology, animal, and clinical studies

2002 ◽  
Vol 6 (1_suppl) ◽  
pp. 65-71 ◽  
Author(s):  
M. Huss ◽  
U. Lehmkuhl
Keyword(s):  
Substance Abuse ◽  
Attention Deficit Hyperactivity Disorder ◽  
Substance Use ◽  
Attention Deficit ◽  
Prospective Studies ◽  
Lower Risk ◽  
Abuse Liability ◽  
Long Term Effects ◽  
Hyperactivity Disorder

This article reviews pharmacological, animal, and human evidence regarding the abuse liability of methylphenidate (MPH). Findings are not always consistent, but evidence converges to suggest that although intravenous methylphenidate has some abuse potential, there is very little potential for oral MPH abuse. Furthermore, the available data suggests that children with Attention-Deficit/Hyperactivity Disorder (ADHD) who are treated with MPH are at lower risk for substance use disorder later in life. More longitudinal, prospective studies are needed to assess the long term effects of MPH treatment in ADHD.

scholarly journals Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Akira Iwanami ◽  
Kazuhiko Saito ◽  
Masakazu Fujiwara ◽  
Daiki Okutsu ◽  
Hironobu Ichikawa
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Extended Release ◽  
Extension Study ◽  
Open Label ◽  
Phase 3 ◽  
Safety And Efficacy ◽  
Hyperactivity Disorder

An amendment to this paper has been published and can be accessed via the original article.

Sign in / Sign up

Export Citation Format

Share Document